Price Alert

Fresenius Medical Care AG... (FMS)

NYSE: FMS · Real-Time Price · USD

24.96

0.09 (0.36%)

At close: Aug 15, 2025, 12:47 PM

Fresenius Medical Care & KGaA Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	4.79B	4.88B	5.08B	4.76B	4.77B	4.72B	4.99B	4.94B	4.83B	4.7B	5B	5.1B	4.76B	4.55B	4.65B	4.44B	4.32B	4.21B
Cost of Revenue	3.58B	3.7B	3.81B	3.61B	3.6B	3.55B	3.64B	3.71B	3.63B	3.56B	3.65B	3.74B	3.41B	3.29B	3.33B	3.17B	3.04B	3B
Gross Profit	1.21B	1.18B	1.27B	1.15B	1.17B	1.17B	1.35B	1.23B	1.2B	1.15B	1.35B	1.36B	1.35B	1.26B	1.32B	1.27B	1.28B	1.21B
Operating Income	425.28M	331.39M	259.39M	462M	425M	217M	439M	324.23M	356.63M	260.94M	-117.67M	471.64M	340.51M	347.67M	449M	504.66M	424.22M	474.25M
Interest Income	21.85M	14.98M	21.57M	16.93M	18M	15.66M	26.87M	25.14M	24.13M	12.08M	25M	16.05M	12.75M	14.11M	28M	15.59M	13.96M	15.26M
Pretax Income	350.55M	250.65M	179.93M	380.53M	340M	129M	320M	235.51M	276.08M	178.37M	277M	395.16M	268.93M	278.57M	382M	436.23M	355.01M	398.18M
Net Income	225.27M	151.22M	66.91M	213.03M	187M	70.96M	187.93M	84.35M	140M	133.85M	194M	230.1M	206M	211.81M	228.74M	273.04M	218.58M	248.95M
Selling & General & Admin	791.98M	750.69M	839.82M	756.15M	771.47M	776M	845M	793.79M	775.24M	782.15M	955M	989.61M	969.49M	871.24M	823M	731.23M	830.18M	711.51M
Research & Development	38.12M	43.48M	50.49M	40.05M	45.59M	48M	66M	53.04M	57.18M	55.76M	62M	61.48M	55.42M	49.67M	68M	52.36M	52.02M	48.65M
Other Expenses	-41.02M	58.42M	120.94M	-112.81M	-76M	-133M	n/a	n/a	n/a	68.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	789.08M	852.59M	1.01B	683.39M	741M	957M	911M	927.4M	840.17M	906.54M	1.02B	1.05B	1.02B	920.91M	891M	783.59M	882.19M	760.16M
Interest Expense	96.58M	95.72M	101.04M	99.1M	103M	103.85M	111.46M	113.86M	104.67M	94.65M	100M	92.53M	84.33M	83.21M	95M	84.03M	83.17M	91.33M
Selling & Marketing Expenses	184.25M	190.49M	n/a	200.32M	n/a	190.56M	n/a	n/a	n/a	203.28M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	4.37B	4.55B	4.83B	4.3B	4.41B	4.51B	4.55B	4.63B	4.47B	4.46B	4.67B	4.79B	4.44B	4.21B	4.22B	3.96B	3.92B	3.76B
Income Tax Expense	78.26M	61.05M	61.06M	116.53M	99.01M	40M	86M	88.45M	81.14M	44.51M	83M	112.23M	62.93M	66.77M	79M	104.99M	75.29M	93.85M
Shares Outstanding (Basic)	586.83M	586.83M	608.17M	586.83M	586.83M	591.33M	587.27M	586.83M	586.83M	595.6M	586.83M	590M	588.56M	586.01M	586.37M	587.19M	585.83M	585.76M
Shares Outstanding (Diluted)	586.83M	586.83M	586.83M	586.83M	586.83M	586.83M	586.83M	586.83M	586.83M	586.83M	586.83M	586.83M	586.29M	586.16M	586M	586.26M	586.13M	586.02M
EPS (Basic)	0.39	0.26	0.12	0.37	0.32	0.12	0.32	0.14	0.24	0.14	0.24	0.39	0.25	0.27	0.39	0.47	0.38	0.43
EPS (Diluted)	0.39	0.26	0.11	0.37	0.32	0.12	0.32	0.14	0.24	0.14	0.24	0.39	0.25	0.27	0.39	0.47	0.38	0.43
EBITDA	822.37M	740.73M	280.97M	845.89M	736.46M	729M	880.45M	803.4M	815M	744.57M	871.36M	989.68M	775.26M	780.74M	914.62M	923.08M	833.72M	877.71M
EBIT	447.13M	346.37M	280.97M	479M	443M	262M	454.51M	349.37M	381M	273M	376.69M	487.69M	353.26M	361.78M	477.51M	520.25M	438.19M	489.51M
Depreciation & Amortization	375.24M	394.36M	n/a	366.26M	387M	387.74M	402.43M	392.64M	406.06M	437.81M	495M	501.98M	427.54M	414.17M	437M	396.4M	395.53M	388.2M